Imipramine for Cytochrome P450 Activity Determination: a Multiple-species Metabolic Probe

Area of Science:

• Pharmacology
• Biochemistry
• Drug Metabolism

Background:

• Imipramine is a tricyclic antidepressant with a complex metabolic pathway.
• Understanding species-specific metabolism is crucial for drug development and safety.

Purpose of the Study:

• To investigate and compare the in vitro metabolic profiles of imipramine across rat, mouse, and human liver microsomes.
• To identify key enzymes involved in imipramine biotransformation.

Main Methods:

• Incubation of imipramine with liver microsomes from rats, mice, and humans.
• Analysis of metabolites using chromatographic and mass spectrometric techniques.
• Heat inactivation of flavin-containing monooxygenases (FMO) to assess their role.

Main Results:

• Rat and human microsomes produced similar imipramine metabolic profiles, including 2-hydroxyimipramine and desipramine.
• Mouse microsomes exhibited a distinct profile with fewer minor metabolites and imipramine N-oxide as the major product.
• Heat treatment confirmed the involvement of FMO in imipramine N-oxide formation.

Conclusions:

• Species-specific differences exist in imipramine metabolism, particularly between mice and humans/rats.
• The metabolic profile of imipramine can serve as a tool to identify active cytochrome P450 enzymes in microsomal fractions.
• Flavin-containing monooxygenases play a role in the N-oxidation of imipramine.